top of page

Merck KGaA's head of global R&D and CMO gives an overview of the company's programs and its appetite for business development

  • Sep 12, 2024
  • 1 min read

Danny Bar-Zohar describes Merck KGaA's three pillars of healthcare research: oncology, neurology, and immunology. Plus, the advantages of the company's heritageand location in Germany.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page